- Home
- LUCD vs NNOX Comparison
LUCD vs NNOX Comparison
Compare LUCD & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LUCD | NNOX |
|---|---|---|
| Founded | 2018 | 2011 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical Electronics |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.9M | 155.6M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | LUCD | NNOX |
|---|---|---|
| Price | $1.48 | $2.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $3.94 | ★ $7.00 |
| AVG Volume (30 Days) | 782.2K | ★ 1.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,346,000.00 | N/A |
| Revenue This Year | $7.69 | $20.19 |
| Revenue Next Year | $155.47 | $137.69 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 79.00 | N/A |
| 52 Week Low | $0.95 | $2.11 |
| 52 Week High | $1.80 | $6.42 |
Technical Indicators
Market Signals| Indicator | LUCD | NNOX |
|---|---|---|
| Relative Strength Index (RSI) | 68.19 | 46.13 |
| Support Level | $1.01 | $2.11 |
| Resistance Level | $1.53 | $3.13 |
| Average True Range (ATR) | 0.08 | 0.14 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 88.57 | 96.15 |
Price Performance
Historical ComparisonAbout LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.